Global PARP Inhibitor Biomarkers Service Market Insights and Forecast to 2028

  • Report ID:257216
  • Industry Name: Medical Care
  • Publishing Date: Jul-22
  • No. of Pages: 88
                              
PARP Inhibitor Biomarkers Service market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PARP Inhibitor Biomarkers Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type BRCA 1 & 2 Testing HRD Testing HRR Testing Others Segment by Application Hospital Clinic Others By Company Myriad Genetics, Inc. Hoffmann-La Roche AG Invitae Corporation NeoGenomics Laboratories, Inc. BPS Bioscience, Inc. By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 BRCA 1 & 2 Testing 1.2.3 HRD Testing 1.2.4 HRR Testing 1.2.5 Others 1.3 Market by Application 1.3.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2017-2028) 2.2 PARP Inhibitor Biomarkers Service Growth Trends by Region 2.2.1 PARP Inhibitor Biomarkers Service Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 PARP Inhibitor Biomarkers Service Historic Market Size by Region (2017-2022) 2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2023-2028) 2.3 PARP Inhibitor Biomarkers Service Market Dynamics 2.3.1 PARP Inhibitor Biomarkers Service Industry Trends 2.3.2 PARP Inhibitor Biomarkers Service Market Drivers 2.3.3 PARP Inhibitor Biomarkers Service Market Challenges 2.3.4 PARP Inhibitor Biomarkers Service Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue 3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2017-2022) 3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2017-2022) 3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by PARP Inhibitor Biomarkers Service Revenue 3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio 3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2021 3.5 PARP Inhibitor Biomarkers Service Key Players Head office and Area Served 3.6 Key Players PARP Inhibitor Biomarkers Service Product Solution and Service 3.7 Date of Enter into PARP Inhibitor Biomarkers Service Market 3.8 Mergers & Acquisitions, Expansion Plans 4 PARP Inhibitor Biomarkers Service Breakdown Data by Type 4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2017-2022) 4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2023-2028) 5 PARP Inhibitor Biomarkers Service Breakdown Data by Application 5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2017-2022) 5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America PARP Inhibitor Biomarkers Service Market Size (2017-2028) 6.2 North America PARP Inhibitor Biomarkers Service Market Size by Type 6.2.1 North America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) 6.2.2 North America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) 6.2.3 North America PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028) 6.3 North America PARP Inhibitor Biomarkers Service Market Size by Application 6.3.1 North America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) 6.3.2 North America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) 6.3.3 North America PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028) 6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country 6.4.1 North America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) 6.4.2 North America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2017-2028) 7.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type 7.2.1 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) 7.2.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) 7.2.3 Europe PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028) 7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Application 7.3.1 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) 7.3.2 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) 7.3.3 Europe PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028) 7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country 7.4.1 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) 7.4.2 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size (2017-2028) 8.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type 8.2.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) 8.2.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) 8.2.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028) 8.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application 8.3.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) 8.3.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) 8.3.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028) 8.4 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region 8.4.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022) 8.4.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America PARP Inhibitor Biomarkers Service Market Size (2017-2028) 9.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Type 9.2.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) 9.2.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) 9.2.3 Latin America PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028) 9.3 Latin America PARP Inhibitor Biomarkers Service Market Size by Application 9.3.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) 9.3.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) 9.3.3 Latin America PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028) 9.4 Latin America PARP Inhibitor Biomarkers Service Market Size by Country 9.4.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) 9.4.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size (2017-2028) 10.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type 10.2.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) 10.2.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) 10.2.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028) 10.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application 10.3.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) 10.3.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) 10.3.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028) 10.4 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country 10.4.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) 10.4.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Myriad Genetics, Inc. 11.1.1 Myriad Genetics, Inc. Company Details 11.1.2 Myriad Genetics, Inc. Business Overview 11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction 11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) 11.1.5 Myriad Genetics, Inc. Recent Developments 11.2 Hoffmann-La Roche AG 11.2.1 Hoffmann-La Roche AG Company Details 11.2.2 Hoffmann-La Roche AG Business Overview 11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction 11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) 11.2.5 Hoffmann-La Roche AG Recent Developments 11.3 Invitae Corporation 11.3.1 Invitae Corporation Company Details 11.3.2 Invitae Corporation Business Overview 11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction 11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) 11.3.5 Invitae Corporation Recent Developments 11.4 NeoGenomics Laboratories, Inc. 11.4.1 NeoGenomics Laboratories, Inc. Company Details 11.4.2 NeoGenomics Laboratories, Inc. Business Overview 11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction 11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) 11.4.5 NeoGenomics Laboratories, Inc. Recent Developments 11.5 BPS Bioscience, Inc. 11.5.1 BPS Bioscience, Inc. Company Details 11.5.2 BPS Bioscience, Inc. Business Overview 11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction 11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) 11.5.5 BPS Bioscience, Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of BRCA 1 & 2 Testing Table 3. Key Players of HRD Testing Table 4. Key Players of HRR Testing Table 5. Key Players of Others Table 6. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global PARP Inhibitor Biomarkers Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022) & (US$ Million) Table 9. Global PARP Inhibitor Biomarkers Service Market Share by Region (2017-2022) Table 10. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global PARP Inhibitor Biomarkers Service Market Share by Region (2023-2028) Table 12. PARP Inhibitor Biomarkers Service Market Trends Table 13. PARP Inhibitor Biomarkers Service Market Drivers Table 14. PARP Inhibitor Biomarkers Service Market Challenges Table 15. PARP Inhibitor Biomarkers Service Market Restraints Table 16. Global PARP Inhibitor Biomarkers Service Revenue by Players (2017-2022) & (US$ Million) Table 17. Global PARP Inhibitor Biomarkers Service Revenue Share by Players (2017-2022) Table 18. Global Top PARP Inhibitor Biomarkers Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2021) Table 19. Ranking of Global Top PARP Inhibitor Biomarkers Service Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by PARP Inhibitor Biomarkers Service Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players PARP Inhibitor Biomarkers Service Product Solution and Service Table 23. Date of Enter into PARP Inhibitor Biomarkers Service Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 26. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2017-2022) Table 27. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2023-2028) Table 29. Global PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 30. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2017-2022) Table 31. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2023-2028) Table 33. North America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 34. North America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million) Table 35. North America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 36. North America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million) Table 37. North America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million) Table 38. North America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million) Table 63. Myriad Genetics, Inc. Company Details Table 64. Myriad Genetics, Inc. Business Overview Table 65. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product Table 66. Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million) Table 67. Myriad Genetics, Inc. Recent Developments Table 68. Hoffmann-La Roche AG Company Details Table 69. Hoffmann-La Roche AG Business Overview Table 70. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product Table 71. Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million) Table 72. Hoffmann-La Roche AG Recent Developments Table 73. Invitae Corporation Company Details Table 74. Invitae Corporation Business Overview Table 75. Invitae Corporation PARP Inhibitor Biomarkers Service Product Table 76. Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million) Table 77. Invitae Corporation Recent Developments Table 78. NeoGenomics Laboratories, Inc. Company Details Table 79. NeoGenomics Laboratories, Inc. Business Overview Table 80. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product Table 81. NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million) Table 82. NeoGenomics Laboratories, Inc. Recent Developments Table 83. BPS Bioscience, Inc. Company Details Table 84. BPS Bioscience, Inc. Business Overview Table 85. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product Table 86. BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million) Table 87. BPS Bioscience, Inc. Recent Developments Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global PARP Inhibitor Biomarkers Service Market Share by Type: 2021 VS 2028 Figure 2. BRCA 1 & 2 Testing Features Figure 3. HRD Testing Features Figure 4. HRR Testing Features Figure 5. Others Features Figure 6. Global PARP Inhibitor Biomarkers Service Market Share by Application: 2021 VS 2028 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Others Case Studies Figure 10. PARP Inhibitor Biomarkers Service Report Years Considered Figure 11. Global PARP Inhibitor Biomarkers Service Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global PARP Inhibitor Biomarkers Service Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global PARP Inhibitor Biomarkers Service Market Share by Region: 2021 VS 2028 Figure 14. Global PARP Inhibitor Biomarkers Service Market Share by Players in 2021 Figure 15. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2021) Figure 16. The Top 10 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2021 Figure 17. North America PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028) Figure 19. North America PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028) Figure 20. North America PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028) Figure 21. United States PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028) Figure 25. Europe PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028) Figure 26. Europe PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028) Figure 27. Germany PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Share by Region (2017-2028) Figure 37. China PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028) Figure 45. Latin America PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028) Figure 46. Latin America PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028) Figure 47. Mexico PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028) Figure 53. Turkey PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022) Figure 57. Hoffmann-La Roche AG Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022) Figure 58. Invitae Corporation Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022) Figure 59. NeoGenomics Laboratories, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022) Figure 60. BPS Bioscience, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.